YONKERS, N.Y., Aug. 25, 2009 (GLOBE NEWSWIRE) -- Aureon Laboratories, Inc., a specialized laboratory dedicated to advancing personalized cancer treatment through predictive pathology, today announced the promotion of Robert Shovlin from the company’s President to President and Chief Executive Officer. Vijay Aggarwal, PhD will step down as CEO, but will remain a member of the company’s board of directors. Dr. Aggarwal will also remain actively involved in shaping the company’s long-term strategies as Aureon continues its evolution.
